In our study, some of the clinical characteristics such as fever, headache, hepatosplenomegaly, and encephalopathy were no more significant in recipients with the IgM−/IgG+ profile compared to the IgM−/IgG− profile. This evidence concerns the gene CD40LG and Encephalopathy.